So far in 2020, NIA has featured three Anti-Coronavirus opportunities and they have all become winners:
On January 28, 2020, NIA announced Kane Biotech (TSXV: KNE) as its favorite Antimicrobial Resistance/Coronavirus stock suggestion at $0.165 per share. On February 24, 2020, KNE reached a high of $0.26 per share for a gain of 57.58% in one month.
On February 27, 2020, NIA announced Muscle Maker (GRIL) as its favorite Cloud Kitchen/Anti-Coronavirus play at $3.75 per share. On March 18, 2020, GRIL reached a high of $5.09 per share for a gain of 35.73% in three weeks.
On April 23, 2020, NIA announced OPKO Health (OPK) as its #1 Covid-19 testing play at $2.08 per share. On May 5, 2020, OPK reached a high of $2.49 per share for a gain of 19.71% in two weeks.
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA was compensated by GRIL USD$30,000 cash for a one-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.